Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-κB to DNA and the subsequent expression of tumor necrosis factor-α and interleukin-1β in macrophages

Journal of Clinical Investigation

Volumn 98, Issue 1, 1996, Pages 78-89

  Ohisson, Bertil G ^a,b   Englund, Mikael C O ^a   Karlsson, Anne Li K ^a   Knutsen, Ellen ^a   Erixon, Cecilia ^a   Skribeck, Henriette ^a   Liu, Yani ^a   Bondjers, Göran ^a   Wiklund, Olov ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

atherosclerosis; gene expression; modified low density lipoproteins; oxysterols; transcription factors

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; DNA BINDING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; INTERNALIZATION; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; ONCOGENE C FOS; PHOSPHORYLATION; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0030056027     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/jci118780     Document Type: Article

References (69)

1. Berliner, J.A., M. Territo, M. Navab, A. Andalibi, F. Parhami, F. Liao, J. Kim, S. Estworthy, A.J. Lusis, and A.M. Fogelman. 1992. Minimally modified lipoproteins in diabetes. Diabetes. 41(Suppl. 2):74-75.
2. Navab, M., S.S. Imes, S.Y. Hama, G.P. Hough, L.A. Ross, R.W. Bork, A.J. Valente, J.A. Berliner, D.C. Drinkwater, H. Laks, and A.M. Fogelman. 1991. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J. Clin. Invest. 88:2039-2046.
3. Rajavashisth, T.B., A. Andalibi, M.C. Territo, J.A. Berliner, M. Navab, A.M. Fogelman, and A.J. Lusis. 1990. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature (Lond.). 344:254-257.
4. Fei, H., J.A. Berliner, F. Parhami, and T.A. Drake. 1993. Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide. Arterioscler. Thromb. 13:1711-1717.
5. Parhami, F., T.Z. Fang, A.M. Fogelman, A. Andalibi, M.C. Territo, and J.A. Berliner. 1993. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J. Clin. Invest. 92:471-478.
6. Berliner, J.A., M.C. Territo, A. Sevanian, S. Ramin, S.A. Kim, B. Bamshad, M. Esterson, and A.M. Fogelman. 1990. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85:1260-1266.
7. Quinn, M.T., S. Parthasarathy, G.L. Fong, and D. Steinberg. 1987. Oxidatively modified low density lipoprotein: a potential role in recruitment and retention of mononcyte/macrophages during atherogenesis. Proc. Natl. Acad. Sci. USA. 84:2995-2998.
8. Hessler, J.R., D.W. Morel, L.J. Lewis, and G.M. Chisholm. 1983. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis. 3:215-222.
9. Hughes, H., B. Mathews, M.L. Lenz, and J.R. Guyton. 1994. Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol. Arterioscler. Thromb. 14:1177-1185.
10. Henriksen, T., S.A. Evensen, and B. Carlander. 1979. Injury to human endothelial cells induced by low density lipoproteins. Scand. J. Clin. Lab. Invest. 39:361-368.
11. Fong, L.G., T.A.T. Fong, and A.D. Cooper. 1991. Inhibition of lipopolysaccharide-induced interleukin-1β mRNA expression in mouse macrophages by oxidized low density lipoprotein. J. Lipid. Res. 32:1899-1909.
12. Hamilton, T.A., M.A. Gouping, and G.M. Chisholm. 1990. Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-α mRNA in stimulated murine peritoneal macrophages. J. Immunol. 144:2343-2350.
13. Collart, M.A., P. Baeuerle, and P. Vassalli. 1990. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol. Cell. Biol. 10:1498-1506.
14. Shakov, A.N., M.A. Collart, P. Vassalli, S.A. Nedospasov, and C.V. Jongeneel. 1990. κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor a gene in primary macrophages. J Exp. Med. 171:35-47.
15. Sen, R., and D. Baltimore. 1986 Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslation mechanism. Cell. 47:921-928.
16. Zhang, Y., and W.N. Rom. 1993. Regulation of interleukin-1β (IL-1β) gene by myobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL-6 motifs. Mol. Cell. Biol. 13:3831-3837.
17. Baeuerle, P.A., and D. Baltimore. 1988. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell. 53:211-217.
18. Baeuerle, P.A., and D. Baltimore. 1988. IκB: a specific inhibitor of the NF-κB transcription factor. Science (Wash. DC) 242:540-546.
19. Shirakawa, F., and S.B. Mizel. 1989. In vitro activation and nuclear translocation of NF-κB catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol. Cell. Biol. 9:2424-2430.
20. Ghosh, S., and D. Baltimore. 1990. Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature (Lond.). 344:678-682.
21. Kerr, L.D., J. Inoue, N. Davis, E. Link, P.A. Baeuerle, H.B. Bose Jr., and I.M. Verma. 1991. The rel-associated pp40 protein prevents DNA binding of rel and NF-κB: relationship with IκBβ and regulation by phosphorylation. Genes & Dev. 5:1464-1476.
22. Liou, H-C., and D. Baltimore. 1993. Regulation of the NF-κB/rel transcription factor and IκB inhibitor system. Curr. Opin. Cell Biol. 5:477-487.
23. Angel, P., and M. Karin. 1991. The role of jun, fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta. 1072:129-157.
24. Karin, M. 1994. Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. Curr. Opin. Cell Biol. 6:415-424.
25. SRF bound to the SRE. EMBO (Eur. Mol. Biol. Organ.) J. 8:2567-2574.
26. Norman, C., M. Runswick, R. Pollock, and R. Treisman. 1988. Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum responsive element. Cell. 55:989-1003.
27. Dalton, S., and R. Treisman. 1992. Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element. Cell. 68:597-612.
28. Marais, R., J. Wynne, and R. Treisman. 1993. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell. 73:381-393.
29. Zhang H., H.J.K. Basra, and U.P. Steinbrecher 1990. Effects of oxidatively modified LDL on cholesterol esterfication in cultured macrophages. J. Lipid Res. 31:1361-1369.
30. 2+ and other actions. Biochim. Biophys. Acta. 770:15-21.
31. Theunissen, J.J.H., R.L. Jackson, H.J.M. Kempen, and R.A. Demel. 1986. Membrane properties of oxysterols, interfacial orientation, influence on membrane permeability and redistribution between membranes. Biochim. Biophys. Acta. 860:66-74.
32. Mattsson Hultén, L., H. Lindmark, U. Diczfalusy, I. Björkhem, M. Ottosson, Y. Liu, G. Bondjers, and O. Wiklund. 1996. Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages. J. Clin. Invest. 97:461-468.
33. Brown, M.S., and J.L. Goldstein. 1975. Cholesterol ester formation in cultured human fibroblasts: stimulation by oxygenated sterols. J. Biol. Chem. 250:4025-4027.
34. Brooks, C.J.W., G. Steel, J.D. Gilbert, and W.A. Harland. 1971. Characterization of a new group of polar sterol from human atherosclerotic plaques. Atherosclerosis. 13:223-237.
35. Harland, W.A., J.D. Gilbert, G. Steel, and C.J.W. Brooks. 1971. The occurence of a new group of polar sterol esters in various stages of human atherosclerosis. Atherosclerosis. 13:239-246.
36. Smith, L.L., and J.E. van Lier. 1970. Sterol metabolism IX, 26-hydroxycholesterol levels in the human aorta. Atherosclerosis. 12:1-14.
37. Jacobson, M.S., P.P. Nair, S.M. Naseem, T.D. Smith, and F.P. Heald. 1981. Oxygenated cholesterols: new risk factors for atherosclerosis? Pediatr. Res. 15:535.
38. Chisholm, G.M., G. Ma, K.C. Irwin, L.L. Martin, K.M. Gunderson, L.F. Linberg, D.W. Morel, and P.E. Dicorleto. 1994. 7-βhydroperoxycholest-5-en-3β-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. Proc. Natl. Acad. Sci. USA. 91:11452-11456.
39. Carpenter, K.L.H., S.E. Taylor, C. van der Veen, B.K. Williamsson, J.B. Ballantine, and M.J. Mitchinson. 1995. Lipids and oxidized lipids in human atherosclerotic lesions at different stages of development. Biochim. Biophys Acta. 1256:141-150.
40. Böyum, A. 1976. Isolation of lymphocytes, granulocytes and macrophages. Scand. J. Immunol. 5(Suppl. 5):9-15.
41. Olofsson, S.-O., K. Boström, U. Svanberg, and G. Bondjers. 1980. Isolation and partial characterization of polypeptide belonging to apolipoprotein B from low density lipoproteins in human plasma. Biochemistry. 19:1059-1064.
42. Steinbrecher, U.P., S. Parthasarathy, D.S. Leake, J.L. Witzum, and D. Steinberg. 1984. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA. 81:3883-3887.
43. Bradford, M.M. 1976. A rapid and a sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
44. Goldstein, J.L., and M.S. Brown. 1974. Binding and degradation of low density lipoproteins by cultured human fibroblasts: comparison of cells from a normal and from patient with homozygous familial hypercholesterolemia. J. Biol. Chem. 249:5153-5162.
45. Hurt-Camejo, E., G. Camejo, B. Rosengren, F. Lopez, C. Ahlström, G. Fager, and G. Bondjers. 1992. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler. Thromb. 12:569-583.
46. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO (Eur. Mol Biol. Organ.) J. 12: 2005-2015.
47. Angel, P., M. Imagawa, R. Chiu, B. Stein, R.J. Imbra, H.J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell. 49:729-739.
48. Cockerill, P.N., and S.P. Klinken. 1990. Octamer-binding proteins in diverse hemopoietic cells. Mol. Cell. Biol. 10:1293-1296.
49. Chirgwin, J.M., A.M. Przybyla, R.J. MacDonald, and W.J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:5294-5298.
50. Wang, A.M., M.V. Doyle, and D.F. Mark. 1989. Quantification of mRNA by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 86:9717-9721.
51. Mattsson, L., H. Johansson, M. Ottosson, O. Bondjers, and O. Wiklund. 1993. Expression of lipoprotein lipase mRNA and secretion in macrophages isolated from human atherosclerotic aorta. J. Clin. Invest. 92:1759-1765.
52. Hamilton, T.A., J.A. Major, and G.M. Chisholm. 1995. The effects of oxidized low density lipoproteins on inducible mouse macrophage gene expression are gene and stimulus dependent. J. Clin. Invest. 95:2020-2027.
53. Newton, R.C. 1990. The production of human interleukin-1beta by blood monocytes. In Cytokines and Lipocortins in inflammation and Differentiation. M. Melli and L. Parente, editors. Wiley-Liss, Inc., New York. 349:217-228.
54. Beutler, B. 1990. Regulation of cachectin biosynthesis occurs at multiple levels. In Cytokines and Lipocortins in Inflammation and Differentiation. M. Melli and L. Parente. Editors. Wiley-Liss, Inc., New York. 349:229-240.
55. Brown, M.S., and J.L. Goldstein, 1983. Lipoprotein metabolism in macrophage: implications for the cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52:223-261.
56. Bhadra, S., M.A.Q. Arshad, Z. Rymaszewski, E. Norman, R. Wherley, and M.T.R. Subbiah. 1991. Oxidation of cholesterol moiety of low density lipoprotein in the presence of human endothelial cells or Cu2+ ions: identification of major products and their effects. Biochem. Biophys. Res. Commun. 176:431-440.
57. Jialal, I., D.A. Freeman, and S.M. Grundy. 1991. Varying susceptibility of different low density lipoproteins to oxidative modification. Arterioscler. & Thromb. 11:482-488.
58. Hu, B., S. Peng, D. Brubaker, and R.J. Morin. 1990. Influence of cholesterol oxides and antioxidants on prostacyclin production by cultured endothelial cells. FASEB J. 4:3734.
59. Pettersen, K.S., K.M. Boberg, A. Stabursvik, and H. Prydz. 1991. Toxicity of oxygenated cholesterol derivatives toward cultured human umbilical vein endothelial cells. Arteroscler. & Thromb. 11:423-428.
60. Sevanian, A., J. Berliner, and H. Peterson. 1991. Uptake, metabolism and cytotoxicity of isomeric cholesterol-5, 6-epoxides in rabbit aortic endothelial cells. J. Lipid Res. 32:147-155.
61. Zhou, Q., T.L. Smith, and F.A. Kummerow. 1993. Cytotoxicity of oxysterols on cultured smooth muscle cells from human umbilical arteries. Proc. Soc. Exp. Biot. Med. 202:75-80.
62. Clare, K., S.J. Hardwick, K.L.H. Carpenter, N. Weeratunge, and M.J. Mitchison. 1995. Toxicity of oxysterols to human monocyte-macrophages. Atherosclerosis. 118:67-75.
63. Thomas, C.E., R.L. Jackson, D.F. Ohlweiler, and G. Ku. 1994. Multiple lipid oxidation products in low density lipoproteins induce interleukin-1beta release from human blood mononuclear cells. J. Lipid. Res. 35:417-427.
64. Steinberger, D., S. Parthasarathy, T.E. Carew, J.C. Khoo, and J.L. Witzum. 1989. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:915-924.
65. Sugiyama, S., K. Kugiyama, M. Ohgushi, K. Fujimoto, and H. Yasue. 1994. Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leucocyte-induced endothelial dysfunction in porcine coronary arteries. Role of protein kinase C. Circ. Res. 74:565-575.
66. Scheinman, R.I., P.C. Cogswell, A.K. Lofquist, and A.S. Baldwin. 1995. Role of transcriptional activation of IκBα in mediation in immunosuppression by glucocorticoids. Science (Wash. DC). 270:283-286.
67. Auphan, N., J.A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis. Science (Wash. DC). 270:286-290.
68. Ares, M.P.S., B. Kallin, P. Eriksson, and J. Nilsson. 1995. Oxidized LDL induces transcription factor acivator protein-1 but inhibits activation of nuclear factor-κB in human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 15:1584-1590.
69. Williams, K.J., and I. Tabas. 1995. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15:551-561.